NEW YORK (GenomeWeb) – Agilent Technologies said that CEO William Sullivan will step down from that role on March 18, 2015, and serve as an advisor to the firm through its fiscal year ending Oct. 31, 2015. Sullivan will be succeeded by Mike McMullen, currently Agilent SVP and president of the company's Chemical Analysis Group. McMullen also was immediately named president and COO of the company in the first step of the transition.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.